{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:12:34Z","timestamp":1788599554715,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bmc.2026.118780","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T21:58:39Z","timestamp":1786917519000},"page":"118780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cationic amino acid-engineered radiopeptides for breast cancer targeting"],"prefix":"10.1016","volume":"142","author":[{"given":"Akanksha","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vasumathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda Majumdar","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apeksha","family":"Khare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drishty","family":"Satpati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118780_bb0005","first-page":"48","article-title":"Steroid receptors and breast carcinoma","volume":"44","author":"Pasi\u0107","year":"1991","journal-title":"Med Pregl"},{"key":"10.1016\/j.bmc.2026.118780_bb0010","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/cac2.12207","article-title":"Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020","volume":"41","author":"Lei","year":"2021","journal-title":"Cancer Commun"},{"key":"10.1016\/j.bmc.2026.118780_bb0015","first-page":"524","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmc.2026.118780_bb0020","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bmc.2026.118780_bb0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/jclinpath-2012-201148","article-title":"Hormone receptor expression in breast cancer: postanalytical issues","volume":"66","author":"Lee","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bmc.2026.118780_bb0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/ijms20020306","article-title":"G-protein coupled estrogen receptor in breast cancer","volume":"20","author":"Hsu","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118780_bb0035","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/1078-0432.CCR-06-0860","article-title":"Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression","volume":"12","author":"Filardo","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2026.118780_bb0040","article-title":"Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer","volume":"12","author":"Zhang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.bmc.2026.118780_bb0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fendo.2014.00066","article-title":"GPER function in breast cancer: an overview","volume":"5","author":"Lappano","year":"2014","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bmc.2026.118780_bb0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11154-007-9034-4","article-title":"SERMs for the treatment and prevention of breast cancer","volume":"8","author":"Swaby","year":"2007","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.bmc.2026.118780_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment","volume":"186","author":"Patel","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmc.2026.118780_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.563165","article-title":"Continuous exposure of breast cancer cells to tamoxifen upregulates GPER-1 and increases cell proliferation","volume":"11","author":"Molina","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bmc.2026.118780_bb0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2016.04.011","article-title":"The G protein-coupled estrogen receptor as a modulator of neoplastic transformation","volume":"429","author":"Jacenik","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bmc.2026.118780_bb0070","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3892\/ijo.2017.4117","article-title":"GPER promotes tamoxifen resistance in ER+ breast cancer cells by reduced Bim proteins through the MAPK\/Erk-TRIM2 signaling axis","volume":"51","author":"Yin","year":"2017","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bmc.2026.118780_bb0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41388-022-02506-4","article-title":"GPER-mediated stabilization of HIF-1\u03b1 contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells","volume":"42","author":"Zhang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2026.118780_bb0080","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.3390\/cells12202460","article-title":"The G protein-coupled estrogen receptor (GPER): a critical therapeutic target for cancer","volume":"12","author":"Hall","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118780_bb0085","doi-asserted-by":"crossref","first-page":"14993","DOI":"10.3390\/ijms241914993","article-title":"GPER: an estrogen receptor key in metastasis and tumoral microenvironments","volume":"24","author":"Tirado-Garibay","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118780_bb0090","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/14728222.2017.1350264","article-title":"GPER-1\/GPR30, a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer","volume":"21","author":"Molina","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bmc.2026.118780_bb0095","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jsbmb.2011.07.002","article-title":"Identification of a GPER\/GPR30 antagonist with improved estrogen receptor counterselectivity","volume":"127","author":"Dennis","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.bmc.2026.118780_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.397","article-title":"The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2026.118780_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046861","article-title":"Synthesis and characterization of tricarbonyl-re\/Tc(I) chelate probes targeting the G protein-coupled estrogen receptor GPER\/GPR30","volume":"7","author":"Burai","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2026.118780_bb0110","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/1541-7786.MCR-14-0289","article-title":"GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding","volume":"12","author":"Nayak","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bmc.2026.118780_bb0115","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/jm9011802","article-title":"Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30","volume":"53","author":"Ramesh","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118780_bb0120","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/cells12040653","article-title":"Promising perspectives of the antiproliferative GPER inverse agonist ER\u03b117p in breast cancer","volume":"12","author":"Kampa","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118780_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060590","article-title":"The peptide ER\u03b117p is a GPER inverse agonist that exerts antiproliferative effects in breast cancer cells","volume":"8","author":"Lappano","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118780_bb0130","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.steroids.2012.02.022","article-title":"ER\u03b117p, a peptide reproducing the hinge region of the estrogen receptor \u03b1 associates to biological membranes: a biophysical approach","volume":"77","author":"Byrne","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.bmc.2026.118780_bb0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molonc.2010.11.001","article-title":"The estrogen receptor alpha-derived peptide ER\u03b117p (P295\u2013T311) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ER\u03b1 status","volume":"5","author":"Pelekanou","year":"2011","journal-title":"Mol Oncol"},{"key":"10.1016\/j.bmc.2026.118780_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.943343","article-title":"Deciphering of a putative GPER recognition domain in ER\u03b1 and ER\u03b136","volume":"13","author":"Acramel","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bmc.2026.118780_bb0145","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s41598-023-28062-9","article-title":"Identification of a human estrogen receptor \u03b1 tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action","volume":"13","author":"Jouffre","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118780_bb0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118780_bb0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12272-019-01125-0","article-title":"Peptide-based targeted therapeutics and apoptosis imaging probes for cancer therapy","volume":"42","author":"Vadevoo","year":"2019","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.bmc.2026.118780_bb0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118780_bb0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12964-021-00741-y","article-title":"Types of nuclear localization signals and mechanisms of protein import into the nucleus","volume":"19","author":"Lu","year":"2021","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.bmc.2026.118780_bb0170","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41573-023-00774-7","article-title":"Artificial intelligence for natural product drug discovery","volume":"22","author":"Mullowney","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2026.118780_bb0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","article-title":"Artificial intelligence in drug development","volume":"31","author":"Zhang","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2026.118780_bb0180","doi-asserted-by":"crossref","first-page":"17319","DOI":"10.1021\/acs.jmedchem.4c01223","article-title":"Discovery of novel PROTAC SIRT6 degraders with potent efficacy against hepatocellular carcinoma","volume":"67","author":"Huang","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118780_bb0185","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1039\/D2SC06860E","article-title":"Discovery of a photoactivatable dimerized STING agonist based on the benzo[b]selenophene scaffold","volume":"14","author":"Liu","year":"2023","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2026.118780_bb0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s13139-014-0315-z","article-title":"Production of [177Lu]Lu for targeted radionuclide therapy: available options","volume":"49","author":"Dash","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.bmc.2026.118780_bb0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mce.2015.07.016","article-title":"The G-protein coupled estrogen receptor, GPER: the inside and inside-out story","volume":"418","author":"Gaudet","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bmc.2026.118780_bb0200","doi-asserted-by":"crossref","first-page":"12605","DOI":"10.1021\/bi00039a016","article-title":"Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis\/mass spectrometric analysis","volume":"34","author":"Seielstad","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2026.118780_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.578250","article-title":"The antitumor peptide ER\u03b117p exerts anti-hyperalgesic and anti-inflammatory actions through GPER in mice","volume":"12","author":"Mallet","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bmc.2026.118780_bb0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00259-002-0982-3","article-title":"Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine","volume":"30","author":"Rolleman","year":"2003","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.bmc.2026.118780_bb0215","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2967\/jnumed.106.036020","article-title":"Indication for different mechanisms of kidney uptake of radiolabeled peptides","volume":"48","author":"Gotthardt","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmc.2026.118780_bb0220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00259-010-1685-9","article-title":"Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice","volume":"38","author":"Vegt","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bmc.2026.118780_bb0225","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3390\/molecules25102314","article-title":"Methods to enhance the metabolic stability of peptide-based PET radiopharmaceuticals","volume":"25","author":"Evans","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118780_bb0230","doi-asserted-by":"crossref","first-page":"25689","DOI":"10.1021\/acs.jmedchem.5c02276","article-title":"Overcoming challenges in the metabolism of peptide therapeutics: strategies and case studies for clinical success","volume":"68","author":"Ma","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118780_bb0235","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bmc.2026.118780_bb0240","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41422-024-00963-y","article-title":"Structural and functional evidence that GPR30 is not a direct estrogen receptor","volume":"34","author":"Liu","year":"2024","journal-title":"Cell Res"},{"key":"10.1016\/j.bmc.2026.118780_bb0245","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2026.118780_bb0250","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:37:20Z","timestamp":1788597440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"alternative-id":["S0968089626002361"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118780","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cationic amino acid-engineered radiopeptides for breast cancer targeting","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118780","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118780"}}